Skip to content
healthcare.dev
Get a free key

Herceptin Hylecta

NDC 50242-077, Trastuzumab and hyaluronidase-oysk, injection, solution, from Genentech, Inc..

Product NDC
50242-077
Status
Listed
Labeler
Genentech, Inc.
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761106
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50242-077 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TRASTUZUMAB600 mg/5mL
  • HYALURONIDASE (HUMAN RECOMBINANT)10000 U/5mL

Pharmacologic classes

Endoglycosidase [EPC]; Glycoside Hydrolases [CS]; HER2/Neu/cerbB2 Antagonists [MoA]; HER2/neu Receptor Antagonist [EPC]

Package NDCNDC-11Package
50242-077-01502420077011 VIAL, SINGLE-DOSE in 1 CARTON (50242-077-01) / 5 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ebf30894-41cf-480c-8bc3-56f592a13813

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=50242-077

Use it

Look up 50242-077 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50242-077 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50242-077. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.